March 9, 2024 · Form 4 insider transaction
Cigler Tessa bought 20,834 shares of Atossa Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date.